Literature DB >> 25938035

Bevacizumab modulates retinal pigment epithelial-to-mesenchymal transition via regulating Notch signaling.

Jing-Jing Zhang1, San-Jun Chu1, Xiao-Lei Sun2, Ting Zhang2, Wei-Yun Shi2.   

Abstract

AIM: To investigate the effect of bevacizumab treatment on Notch signaling and the induction of epithelial-of-mesenchymal transition (EMT) in human retinal pigment epithelial cells (ARPE-19) in vitro.
METHODS: In vitro cultivated ARPE-19 cells were treated with 0.25 mg/mL bevacizumab for 12, 24, and 48h. Cell morphology changes were observed under an inverted microscope. The expression of zonula occludens-1 (ZO-1), vimentin and Notch-1 intracellular domain (NICD) was examined by immunofluorescence. The mRNA levels of ZO-1, α-SMA, Notch-1, Notch-2, Notch-4, Dll4, Jagged-1, RBP-Jk and Hes-1 expression were evaluated with quantitative real-time polymerase chain reaction (qRT-PCR). The protein levels of α-SMA, NICD, Hes-1 and Dll-4 expression were examined with Western blot.
RESULTS: Bevacizumab stimulation increased the expression of α-SMA and vimentin in ARPE-19 cells which changed into spindle-shaped fibroblast-like cells. Meanwhile, the mRNA expression of Hes-1 increased and the protein expression of Hes-1 and NICD also increased, which Notch signaling was activated. The mRNA expression of Notch-1, Jagged-1 and RBP-Jk increased at 48h, and while Dll4 mRNA and protein expression did not change after bevacizumab treatment.
CONCLUSION: Jagged-1/Notch-1 signaling may play a critical role in bevacizumab-induced EMT in ARPE-19 cells, which provides a novel insight into the pathogenesis of intravitreal bevacizumab-associated complication.

Entities:  

Keywords:  Notch signaling; bevacizumab; epithelial-to-mesenchymal transition; retinal pigment epithelial cells

Year:  2015        PMID: 25938035      PMCID: PMC4413575          DOI: 10.3980/j.issn.2222-3959.2015.02.06

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation.

Authors:  Michela Noseda; Graeme McLean; Kyle Niessen; Linda Chang; Ingrid Pollet; Rachel Montpetit; Réza Shahidi; Katerina Dorovini-Zis; Linheng Li; Benjamin Beckstead; Ralph E Durand; Pamela A Hoodless; Aly Karsan
Journal:  Circ Res       Date:  2004-02-26       Impact factor: 17.367

Review 2.  Notch signaling in vascular development and physiology.

Authors:  Thomas Gridley
Journal:  Development       Date:  2007-07-04       Impact factor: 6.868

Review 3.  The treatment of wet age-related macular degeneration.

Authors:  Antonia M Joussen; Norbert Bornfeld
Journal:  Dtsch Arztebl Int       Date:  2009-05-01       Impact factor: 5.594

4.  Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.

Authors:  Sara Brandi Bloch; Henrik Lund-Andersen; Birgit Sander; Michael Larsen
Journal:  Am J Ophthalmol       Date:  2013-05-08       Impact factor: 5.258

5.  Automated diagnosis of Age-related Macular Degeneration using greyscale features from digital fundus images.

Authors:  Muthu Rama Krishnan Mookiah; U Rajendra Acharya; Joel E W Koh; Vinod Chandran; Chua Kuang Chua; Jen Hong Tan; Choo Min Lim; E Y K Ng; Kevin Noronha; Louis Tong; Augustinus Laude
Journal:  Comput Biol Med       Date:  2014-07-30       Impact factor: 4.589

6.  Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.

Authors:  Daniel Barthelmes; Richard Walton; Anna E Campain; Judy M Simpson; Jennifer J Arnold; Ian L McAllister; Robyn H Guymer; Alex P Hunyor; Rohan W Essex; Nigel Morlet; Mark C Gillies
Journal:  Br J Ophthalmol       Date:  2014-09-23       Impact factor: 4.638

7.  Risk of scar in the comparison of age-related macular degeneration treatments trials.

Authors:  Ebenezer Daniel; Cynthia A Toth; Juan E Grunwald; Glenn J Jaffe; Daniel F Martin; Stuart L Fine; Jiayan Huang; Gui-shuang Ying; Stephanie A Hagstrom; Katrina Winter; Maureen G Maguire
Journal:  Ophthalmology       Date:  2013-12-04       Impact factor: 12.079

Review 8.  The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness.

Authors:  Zhiwei Wang; Yiwei Li; Dejuan Kong; Fazlul H Sarkar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

Review 9.  Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.

Authors:  X Chen; W Xiao; X Liu; M Zeng; L Luo; M Wu; S Ye; Y Liu
Journal:  Curr Mol Med       Date:  2014-05       Impact factor: 2.222

10.  A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy.

Authors:  Rob J Van Geest; Sarit Y Lesnik-Oberstein; H Stevie Tan; Marco Mura; Roel Goldschmeding; Cornelis J F Van Noorden; Ingeborg Klaassen; Reinier O Schlingemann
Journal:  Br J Ophthalmol       Date:  2012-01-29       Impact factor: 4.638

View more
  2 in total

1.  Proteomic analysis of anti-angiogenic effects by conbercept in the mice with oxygen induced retinopathy.

Authors:  Ji Jin; Lei Chen; Gao-Qin Liu; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

2.  Resveratrol reverses the adverse effects of bevacizumab on cultured ARPE-19 cells.

Authors:  Murali Subramani; Murugeswari Ponnalagu; Lekshmi Krishna; Nallathambi Jeyabalan; Priyanka Chevour; Anupam Sharma; Chaitra Jayadev; Rohit Shetty; Nargis Begum; Govindaraju Archunan; Debashish Das
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.